Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (26)

2024

  1. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

    Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23

  2. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness

    Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 150-157

2023

  1. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  2. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  3. RSPO4 is a potential risk gene of stages III–IV, grade C periodontitis through effects on innate immune response and oral barrier integrity

    Journal of Clinical Periodontology, Vol. 50, Núm. 4, pp. 476-486

  4. Single-cell immune profiling of Meniere Disease patients

    Clinical Immunology, Vol. 252

2022

  1. Methods for the Detection of Circulating Biomarkers in Cancer Patients

    Advances in experimental medicine and biology, Vol. 1379, pp. 525-552

  2. Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin

    Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 16, pp. 4416-4427

2021

  1. Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS (Intensive Care Medicine, (2020), 46, 12, (2200-2211), 10.1007/s00134-020-06192-2)

    Intensive Care Medicine

  2. Letter to the editor: “Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer”

    Oral Oncology

  3. Saliva gene promoter hypermethylation as a biomarker in oral cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  4. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  5. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

2020

  1. Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis

    Journal of Clinical Medicine, Vol. 9, Núm. 5

  2. Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14

  3. Prognostic factors that modify outcomes of vestibular rehabilitation in elderly patients with falls

    Aging Clinical and Experimental Research, Vol. 32, Núm. 2, pp. 223-228

  4. Response to commentary by Lu and Wang on “Salivary biomarkers for cancer diagnosis: a meta-analysis”

    Annals of Medicine

  5. Salivary biomarkers for cancer diagnosis: a meta-analysis

    Annals of Medicine, Vol. 52, Núm. 3-4, pp. 131-144

2019

  1. A novel saliva-based mirna signature for colorectal cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  2. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy

    Cells, Vol. 8, Núm. 12